Autopsy report · NCT01275287

Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab

“the study failed to enroll any patient and sponsor wished to stop.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

University of North Carolina, Chapel Hill

Sponsor type

University, hospital or other

Conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Interventions

Standard of care treatment; eculizumab

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)
  “Due to low enrollment, the Sponsor decided to prematurely terminate the study” (79% match in meaning)
• Evaluate the Performance of JOURNEY II CR and JOURNEY II BCS in TKA Populations
  “Study design is not reasonable and sponsor decided to terminate the study. No patient enrolled by now” (77% match in meaning)
• The Performance and Safety of Petit Drill in the French Paediatric Population: a Post-market Clinical Follow-up Study
  “Due to difficulty in recruiting patients, the Sponsor decided to prematurely stop the study” (77% match in meaning)
• Manual Therapy/Exercises vs. Physiotherapy/Back School vs. Waiting List in Patients With Chronic Low Back Pain
  “Sponsor did not want to continue the study.” (75% match in meaning)
• CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
  “Sponsor stopped the study.” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.